NRX Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $1.3M | $70.8M | — |
| FY2019 | $2.6M | $32.1M | $877.0K |
| FY2020 | $46.7M | $2.9M | $1.9M |
| FY2021 | $11.9M | $32.7M | $27.6M |
| FY2022 | $18.4M | $25.8M | $20.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $1.3M | $70.8M | — |
| FY2019 | $2.6M | $32.1M | $877.0K |
| FY2020 | $46.7M | $2.9M | $1.9M |
| FY2021 | $11.9M | $32.7M | $27.6M |
| FY2022 | $18.4M | $25.8M | $20.1M |